Dendreon Overstated Demand For Provenge: Investors
Shareholder Michael Wendt claims that the false statements artificially inflated Dendreon's stock price, a violation of the Securities Exchange Act. Wendt also accuses Dendreon officers and directors of defrauding investors by trading on the false information.
Wendt seeks to establish a class of investors that purchased Dendreon stock between April 29, 2010, when...
To view the full article, register now.